Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15S1-CD163 and PK15S10-CD163 cells by Xie, Jiexiong et al.
Xie et al. Vet Res  (2018) 49:67  
https://doi.org/10.1186/s13567-018-0569-z
RESEARCH ARTICLE
Preferential use of Siglec-1 or Siglec-10 
by type 1 and type 2 PRRSV strains to infect 
 PK15S1–CD163 and  PK15S10–CD163 cells
Jiexiong Xie* , Isaura Christiaens, Bo Yang, Ivan Trus, Bert Devriendt, Tingting Cui, Ruifang Wei 
and Hans J. Nauwynck*
Abstract 
Cellular entry mediators define whether the cell is permissive to PRRSV infection. Porcine sialoadhesin (pSn, Siglec-1) 
and CD163 are main entry mediators facilitating infection of porcine macrophages by PRRSV. Recently, Siglec-10 was 
demonstrated to be an alternative receptor for PRRSV. To examine if virulence and pathogenicity of PRRSV strains 
could be correlated with the use of different Siglecs, a PK15 cell line recombinantly expressing Siglec-1 and CD163 
 (PK15S1–CD163) and a PK15 cell line recombinantly expressing Siglec-10 and CD163  (PK15S10–CD163) were used to 
compare the virus replication of 7 genotype 1 subtype 1 strains (G1s1), 2 genotype 1 subtype 3 (G1s3) strains and 5 
genotype 2 (G2) strains. Some strains (08VA (G1s1), 13V117 (G1s1), 17V035 (G1s1), VR2332 (G2)) were poor virus pro-
ducers (<104  TCID50/mL), while other strains (07V063 (G1s1), 13V091 (G1s1), Su1-Bel (G1s3), MN-184 (G2), Korea17 (G2) 
and SDSU-73 (G2)) easily grew up to ≥106  TCID50/mL.  PK15S10–CD163 cells exhibited a higher efficiency in virus produc-
tion per infected cell than the  PK15S1–CD163 cells. The G1s1 strains LV and 07V063 infected more cells in the  PK15S1–
CD163, whereas the 94V360 and 08VA strains preferred  PK15S10–CD163. The highly virulent G1s3 strains Lena and Su1-Bel 
showed a strong preference for  PK15S1–CD163. The G2 strains MN-184, SDSU-73, Korea17 had a much higher infection 
rate in  PK15S10–CD163, while the reference strain VR2332 and the NADC30 strain had a slight preference for  PK15S1–CD163. 
Differences in receptor use may influence the outcome of a PRRSV infection in pigs and explain in part the virulence/
pathogenicity of PRRSV strains.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Porcine reproductive and respiratory syndrome virus 
(PRRSV) is a member of the Arterivirus, genus, fam-
ily Arteriviridae, order Nidovirales [1] causing respira-
tory disorders in piglets and reproductive problems in 
adult animals. PRRSV infections cause major economic 
losses in the pig industry worldwide [2, 3]. In  vivo, the 
virus infects a subpopulation of tissue macrophages, 
and also subpopulation of monocyte and bone marrow 
derived dendritic cells [4–9]. In  vitro, efficient PRRSV 
replication is observed in primary porcine alveolar mac-
rophages (PAM), differentiated monocytes [10] and for 
certain strains (mainly after adaptation) in African green 
monkey kidney derived cells, e.g. MARC-145 [11]. Por-
cine sialoadhesin (pSn, also known as Siglec-1) and 
porcine CD163 (pCD163) have been reported to be the 
main entry mediators for PRRSV [12–14]. In the classic 
PRRSV entry model, the virus binds to and is internal-
ized into the macrophages via pSn through interacting 
with the viral GP5/M protein complex. Once inside the 
cell, pCD163 mediates the viral disassembly and genome 
release. However, recent studies demonstrated that 
PRRSV do not only infect sialoadhesin positive, but also 
sialoadhesin negative cells [15, 16]. Moreover, Siglec-1 
knockout pigs are still susceptible to PRRSV [17]. These 
results indicated that PRRSV may use alternative entry 
mediators to infect the host. Indeed, we have recently 
demonstrated that Siglec-10, a sialic acid binding pro-
tein belonging to the same family as Siglec-1, is able to 
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facilitate the infection of non-permissive cells by PRRSV 
[18]. It is very well possible that even more siglecs and/
or siglec-like molecules exist. To analyze the receptor use 
of different PRRSV strains (7 G1s1, 2 G1s3 and 5 G2), a 
stably transfected cell line expressing both Siglec-10 and 
CD163  (PK15S10–CD163) was established and compared 
with the earlier developed cell line stably expressing both 
Siglec-1 and CD163  (PK15S1–CD163) [10].
Materials and methods
Cells and viruses
PK15 cells were cultivated in Dulbecco’s Modified Eagle 
Medium (D-MEM) supplemented with 10% fetal bovine 
serum (FBS), 100  U/mL penicillin, 0.1  mg/mL strep-
tomycin. MARC-145 cells,  PK15S1–CD163 and  PK15S10–
CD163 cells were cultivated in Modified Eagle Medium 
(MEM), supplemented with 10% FBS, 100  U/mL peni-
cillin, 0.1  mg/mL streptomycin. The following PRRSV 
strains were analyzed in our study: LV (prototype G1s1, 
13 passages in PAM), 94V360 (G1s1, 3 passages in 
PAM), 07V063 (G1s1, 3 passages in PAM), 08VA (G1s1, 
4 passages in PAM), 13V091 (G1s1, 4 passages in PAM), 
13V117 (G1s1, 3 passages in PAM), 17V035 (G1s1, 2 pas-
sages in PAM), Lena (G1s3, 4 passages in PAM), Su1-Bel 
(G1s3, 4 passages in PAM), VR-2332 (G2, 4 passages in 
MARC-145 and 2 passages in PAM), MN-184 (G2, 3 pas-
sages in MARC-145 and 3 passages in PAM), SDSU-73 
(G2; 3 passages in MARC-145 and 3 passages in PAM), 
NADC30 (G2, 3 passages in MARC-145 and 3 passages 
in PAM) and Korean17 (3 passages in PAM). Information 
on the origin and virus characteristics are summarized in 
Table 1.
Transfection and clone selection
PK15 cells were transfected in the presence of lipo-
fectamine 3000 (Invitrogen) according to the manufac-
turer’s instructions. PK15 cells were first transfected with 
a plasmid containing the Siglec-10 cDNA and a geneticin 
resistance gene as described previously [18]. Afterwards, 
the obtained  PK15S10 cells were transfected with a plas-
mid containing the CD163 cDNA and a zeocin resistance 
gene and single cell cloned. For the selection of  PK15S10–
CD163 cells, zeocin (200  μg/mL, Invitrogen) was used. 
Cells were further sorted and subcloned three times 
with a FACSAria III (Becton–Dickinson) to obtain stably 
expressing cell clones (Figure 1).
Fluorescence activated cell sorting (Facs)
Cells were trypsinized with 0.075% trypsin (Sigma-
Aldrich) and washed 2 times and harvested with MEM 
containing 1  mM EDTA and 1% FBS. The cells were 
labeled with anti-CD163 monoclonal antibodies (2A10, 
 IgG1, AbD, serotec) or mAb against siglec-10 [18]. Iso-
type-matched monoclonal antibodies (13D12, directed 
against PRV gD) [19] were used as control. The incuba-
tion was performed in the presence of 1 mM EDTA and 
1% FCS for 30  min on ice. AlexaFluor 647-conjugated 
polyclonal antibodies against mouse  IgG1 (Invitrogen) 
Table 1 Information on the virus strains used in the study 
NA: not available; S1: PK-15S1–CD163; S10: PK-15S10–CD163; G1s1: type1 subtype 1; G1s3: type1 subtype 3; G2: type 2
Strain Year of isolation Origin Passages in MARC-
145/PAM
Virulence 
score
Macrophage (mø) 
tropism
Genotype Accession number References
LV 1991 Netherlands 13 in PAM 1+ Sn+ mø G1s1 M96262 [28]
94V360 1994 Belgium 3 in PAM NA NA G1s1 JF304781 [31]
07V063 2007 Belgium 3 in PAM 3+ Sn+ and  Sn− mø G1s1 GU737264 [16]
08VA 2008 Belgium 4 in PAM 0 Sn+ and  Sn− mø G1s1 GU737266 [16]
13V091 2013 Belgium 4 in PAM 4+ Sn+ and  Sn− mø G1s1 KT159248 [16]
13V117 2013 Belgium 3 in PAM 0 Sn+ and  Sn− mø G1s1 KT159249 [16]
17V035 2017 Belgium 2 in PAM 0 NA G1s1 This study NA
Lena 2007 Belarus 4 in PAM 6+ Sn+ and  Sn− mø G1s3 JF802085 [32]
SU1-Bel 2010 Belarus 4 in PAM 5+ NA G1s3 KP889243 [33]
VR2332 1990 USA 4 in MARC-145 and 2 
in PAM
2+ Sn+ and  Sn− mø G2 U87392 [34]
SDSU-73 1995 USA 3 in MARC-145 and 3 
in PAM
4+ NA G2 JN654458 [28]
MN-184 2001 USA 3 in MARC-145 and 3 
in PAM
5+ Sn+ and  Sn− mø G2 EF488739 [28]
NADC-30 2008 USA 3 in MARC-145 and 3 
in PAM
3+ NA G2 JN654459 [28]
Korean 17 2017 Korean 3 in PAM NA NA G2 This study NA
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were used as secondary antibodies. Incubation was per-
formed in the presence of 1 mM EDTA and 1% FCS for 
30 min on ice in the dark. FACS sorting was performed 
with a FACSAria III. Two million cells were used for each 
sorting, doublets were excluded with a gating strategy 
based on forward light scatter and sideward light scatter. 
Dead cells were excluded with propidium iodide stain-
ing. Sorted cells were collected in the RPMI/DMEM 
(1:1) supplemented with 30% FCS, 1% P/S and 0.5% 
gentamicin and directly used for a subcloning strat-
egy. Subcloning was performed by limiting dilution as 
described for cloning of hydridomas [20]. The expression 
of Siglec-10 and CD163 in the subclones was checked by 
immunofluorescence.
Immunofluorescence staining
Cells were fixed with methanol for single stainings. Pri-
mary monoclonal antibodies were used: mAb 1G10 
against Siglec-10  (IgG1) [18]; mAb 41D3 against Siglec-1 
[21] or mAb 2A10 against CD163  (IgG1, AbD, serotec). 
13D12 was used as isotype control. As a secondary anti-
body, fluorescein isothiocyanate (FITC)-conjugated poly-
clonal goat anti-mouse IgG antibodies (Invitrogen) were 
used. The expression of Siglec-1, Siglec-10 and CD163 
was examined with a fluorescence microscope (Leica 
Microsystems GmbH, Germany). For double staining of 
Siglec-10 and CD163, goat polyclonal antibodies against 
CD163 (R&D Systems, Minneapolis) and mAb 1G10 
against Siglec-10 were incubated at 37  °C for 1  h. After 
three washes with PBS, cells were incubated with rab-
bit anti-goat AF594 for 1 h at 37 °C. After blocking with 
negative goat serum for 30 min at 37 °C cells were further 
incubated with FITC-labelled goat anti-mouse IgG. Cell 
nuclei were stained with Hoechst 33 342.
Flow cytometry
PK15S10–CD163,  PK15S1–CD163 and PK-15 cells were trypsi-
nized with 0.075% trypsin (Sigma-Aldrich).  106 cells 
of each cell line were collected for each experimental 
condition. Cells were washed two times with PBS. For 
intracellular staining, cells were fixed with 4% PF and per-
meabilized with 0.1% triton before incubation with pri-
mary antibodies. For surface staining, cells were directly 
incubated with the primary antibodies against CD163 
(mouse  IgG1, 2A10), Siglec-10 (mouse  IgG1, 1G10), Sn 
(mouse  IgG1, 41D3), PRV gD (isotype matched control 
mAb mouse  IgG1, 13D12). AF647-conjugated goat anti-
mouse  IgG1 antibodies (Invitrogen) were used as second-
ary antibodies. The staining procedures were the same as 
described for Facs above. Flow cytometry was performed 
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Figure 1 Construction strategy and immunofluorescence staining of PK15S10–CD163 cells. A Schematic representation of the construction of 
the  PK15S10–CD163 cell line. To construct a cell line co-expressing Siglec-10 and CD163, PK15 cells were first transfected with a plasmid containing 
Siglec-10 cDNA and a geneticin resistance gene. The cells were subcloned and screened for Siglec-10 expressing cells. After selection for geneticin 
resistance, the obtained  PK15S10 cells were transfected with a plasmid containing the CD163 cDNA and a zeocin resistance gene, which allowed the 
selection of cells expressing both Sn and CD163. B Immunofluorescence staining for  PK15S10–CD163. The green color represents Siglec-10, while the 
red color represents CD163. The nuclei of the cells are blue (Hoechst). Scale bar: 25 µm.
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with Cytoflex (Beckman coulter). 10  000 events were 
recorded and 1000 events were displayed, doublets were 
excluded with a gating strategy based on forward light 
scatter and sideward light scatter.
Analysis of PRRSV attachment, internalization, disassembly 
and infection in  PK15S1–CD163 and  PK15S10–CD163 cells 
by immunofluorescence
Cells were seeded at 2 × 105 cells/mL (1  mL/well in 
24-well plate) and after 3  days of cultivation, cells were 
inoculated with PAM grown LV at a multiplicity of infec-
tion (MOI) of 1. After 1 h of incubation at 4 °C, cells were 
fixed with methanol in order to assess virus attachment. 
To quantify the internalized particles, to analyze virus 
disassembly and virus infection, cells were fixed after 1, 5 
and 24 h of incubation at + 37 °C with ice-cold methanol 
(−20 °C, 10 min). The virus was stained with mAb 13E2, 
directed against PRRSV nucleocapsid  (IgG1, 1:50) and 
secondary FITC-conjugated polyclonal goat anti-mouse 
IgG antibodies (Invitrogen, Molecular Probes, Belgium). 
Virus particles and number of PRRSV infected cells were 
counted on images acquired with a TCS SPE confocal 
system (Leica Microsystems GmbH, Germany). Twenty 
randomly selected fields were taken for calculating the 
virus particles and percentage of infected cells.
PRRSV infection kinetics in  PK15S1–CD163 and  PK15S10–CD163 
cells
PK15S10–CD163 and  PK15S1–CD163 cells were seeded at a 
concentration of 200 000 cells/mL in 24 well plates with 
glass inserts (1 mL/well). After 3 days of cultivation, cells 
were inoculated with 200 µL of a virus stock containing 
 105  TCID50/mL of four different PRRSV strains grown on 
PAMs: LV, Lena, MN-184 and VR2332. After 0, 12, 24, 
48 and 72 hours post-inoculation (hpi), supernatant was 
collected, centrifuged (10  min, 300  g, 4  °C) and stored 
at −70  °C prior to virus titration on PAM [6]. Cells on 
inserts were fixed with methanol at the indicated time 
points and stained for immunofluorescence analysis. The 
PRRSV N protein was stained with primary mAb 13E2 
directed against PRRSV nucleocapsid  (IgG1, 1:50) and 
secondary FITC-conjugated polyclonal goat anti-mouse 
IgG antibodies (Invitrogen, Molecular Probes, Belgium). 
Virus positive cells were counted on images acquired 
with a TCS SPE confocal system (Leica Microsystems 
GmbH, Germany). Twenty images were taken for each 
experimental condition, and the percentage of infected 
cells was assessed with Image J.
Furthermore, another ten genetically different viral 
strains were used for comparison of the replication in 
both  PK15S10–CD163,  PK15S1–CD163 cell line using the 
sample protocol as described above (Table  1). The ten 
different PRRSV strains grown on PAMs were: 94V360, 
07V063, 08VA, 13V091, 13V117, 17V024, Korean17, 
Su1-Bel, NADC 30, SDSU73.
Statistical analysis
Infection experiments for the four prototype strains 
were performed with at least three replicates. Results 
were compared using a two-way ANOVA test (Graph-
Pad Prism 5) followed by Šidak’s multiple comparisons 
test. Differences were considered statistically signifi-
cant at p < 0.05. Variance between intracellular and 
extracellular titers for the two cell lines were analyzed 
in univariate main effect model with SPSS. Differences 
were considered statistically significant at p < 0.05.
Results
Construction of  PK15S10–CD163 and detection of receptors 
in the  PK15S1–CD163 and  PK15S10–CD163 cell lines 
by immunofluorescence staining and flow cytometry
PK15 cells, stably expressing Siglec-10  (PK15S10) were 
produced as previously described [18]. Then,  PK15S10 
cells were transfected with CD163 and screened with 
zeocin and followed by Facs sorting for selection of 
double receptors positive cell clones as indicated in 
Figure  1. The presence of Siglec-10 and CD163 was 
confirmed by immunofluorescence staining (Figure  1). 
The cells maintained a stable expression of Siglec-10 
and CD163 for at least 15 passages.  PK15S1–CD163 cells 
were previously produced by Delrue et al. [10]. Expres-
sion of Siglec-1, Siglec-10 and CD163 was analyzed in 
 PK15S1–CD163 and  PK15S10–CD163 cells with immunofluo-
rescence staining and flow cytometry. As shown in Fig-
ure 2, the  PK15S1–CD163 cells were positive for Siglec-1 
and CD163, but negative for Siglec-10.  PK15S10–CD163 
cells on the other hand were positive for Siglec-10 and 
CD163, but negative for Siglec-1. PK15 cells were nega-
tive for all of the three receptors (Figure 2).
Attachment, internalization, disassembly and infection 
of  PK15S1–CD163 and  PK15S10–CD163 cells with PRRSV
Our aim was to compare the attachment, internali-
zation, disassembly and infection of PRRSV in the 
 PK15S10–CD163 and  PK15S1–CD163 cell lines. As shown 
in Figure  3, virus particles clearly attached to cells of 
both cell lines and subsequently were internalized into 
the cells. After internalization, the virus particles were 
uncoated in order to release the viral genome. Finally, 
infection occurred (Figure  3). In general, in line with 
the binding and entry results, the LV strain infected 
 PK15S1–CD163 cells better than  PK15S10–CD163 cells.
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Figure 2 Detection of receptor expression in PK15, PK15S1–CD163 and PK15S10–CD163 cell lines. Expression of receptors (Siglec-1, Sigle-10 and 
CD163) in PK15,  PK15S1–CD163 and  PK15S10–CD163 were analyzed by confocal microscopy (left) and flow cytometry (right). Scale bar: 25 µm.
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Figure 3 Attachment, internalization, disassembly and infection of PRRSV in PK15S1–CD163 and PK15S10–CD163 cells. Cells were inoculated 
with PAM-grown LV. Then, the different stages of viral replication were visualized with a staining for the nucleocapsid of PRRSV. The experiments 
were performed in triplicate; the numbers on the images represent mean ± SD of 3 repeats. Scale bar: 25 µm.
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Infection kinetics in  PK15S1–CD163 and  PK15S10–CD163 cells 
upon inoculation with genotype I (LV and Lena) and II 
(VR2332, MN184) PRRSV reference strains
PK15S1–CD163 and  PK15S10–CD163 cells were inoculated 
with PAM-grown LV, Lena, MN-184 and VR2332 and at 
1, 12, 24, 48 and 72 hpi, cells were fixed and stained by 
immunofluorescence. Figure  4 shows that the two cell 
lines are susceptible to all used PRRSV strains and that 
the infection level increased with time. In general, PAM-
grown Lena and MN-184 strains could infect  PK15S1–
CD163 and  PK15S10–CD163 cells more efficiently than the 
prototype LV and VR2332 strains (p = 0.0081). The 
percentage of cells infected with LV, Lena, and VR2332 
strains was significantly higher in  PK15S1–CD163 cells 
than in  PK15S10–CD163 cell line (p < 0.0001). The PAM-
grown MN-184 strain showed a significantly higher 
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Figure 4 PRRSV infection kinetics in PK15S1–CD163 and PK15S10–CD163 cells. Cells were inoculated with PAM-grown PRRSV strains (LV, Lena, 
VR-2332 and MN-184). After 0, 12, 24, 48 and 72 h of infection, cells were fixed and an immunofluorescence staining was performed (A). The number 
of infected cells was counted and expressed as percentage of infected cells (B). In addition, the virus titers in supernatants were determined. The 
blue line represents the kinetics of the virus infection rate/titers in  PK15S1–CD163 cells, while the red line represents the kinetics of the virus infection 
rate/titer in  PK15S10–CD163 cells. G1s1 = genotype 1 subtype 1; G1s3 = genotype 1 subtype 3; G2 = genotype 2; S1 = PK15S1–CD163, S10 = PK15S10–
CD163. Value of titers and infection proportion presented on the curve graph represent mean ± SD of three experiments. Scale bar: 200 µm.
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infection rate in  PK15S10–CD163 cells (71.2 ± 5.1%) than 
in  PK15S1–CD163 cells (44.9 ± 1.8%, p < 0.0001). For the 
LV and VR2332 strains, the virus replication kinetics 
was 5–12 fold lower compared to the MN-184 and Lena 
strains; infection was observed only in some cells both 
for  PK15S1–CD163 and  PK15S10–CD163 cells. Interestingly, 
although there is a higher infection rate for LV, Lena 
and VR2332 strains in  PK15S1–CD163 than  PK15S10–CD163 
cells, the virus production in both cell lines was similar. 
This points towards a higher virus yield per cell for the 
 PK15S10–CD163 cells. For the MN-184 strain, a higher virus 
infection rate and also a higher virus production were 
found in  PK15S10–CD163 cells.
Analysis of Siglec-1, Siglec-10 and CD163 surface 
and cytoplasm expression in  PK15S1–CD163 and  
PK15S10–CD163 cells
Based on the results of the binding and internalization 
assays, we found that irrespective of the PRRSV strain 
more virus particles were attached and internalized in 
the  PK15S1–CD163 cells. This might explain the higher 
virus infection rates in  PK15S1–CD163 cells for the LV, Lena 
and VR2332 strains. Interestingly, a similar virus produc-
tion was observed for both cell lines, which might indi-
cate that the virus particles are more anchored to the 
surface of the  PK15S1–CD163 cells rather than released in 
the extracellular environment. As shown Siglec-1+ cells 
showed more binding of virus particles than Siglec-10+ 
cells. We hypothesize that produced virus is anchored at 
the cell surface, preventing the release of virus particles. 
To show differences in subcellular expression patterns 
of Siglec-1 and Siglec-10, we performed a surface and 
intracellular staining. As shown in Figure  5, Siglec-1 is 
expressed on the surface of  PK15S1–CD163 cells to a higher 
level than Siglec-10 on the surface of  PK15S10–CD163 cells. 
In both cell lines, CD163 is expressed on the surface and 
in the cytoplasma with little difference between the two 
cell lines.
Replication kinetics of ten genetically distant PRRSV 
strains in  PK15S1–CD163 and  PK15S10–CD163 cells
To analyze the possible Siglec preference of different 
PRRSV strains, we assessed the virus infection/produc-
tion of additionally 7 genotype 1 subtype 1 strains (G1s1) 
(94V360, 07V063, 08VA, 13V091, 13V117, 17V035); 1 
genotype 1 subtype 3 (G1s3) strains (Su1-Bel) and 3 gen-
otype 2 strains (SDSU-73, NADC30-like and Korea17). 
Replication kinetics (both virus infection and virus pro-
duction) were compared in the two cell lines (Figure 6). In 
general, the  PK15S10–CD163 cell line exhibited a higher effi-
ciency in virus production per infected cell as compared 
to  PK15S1–CD163 (Additional file  1). For G1s1 strains, 
07V063 strain preferred  PK15S1–CD163, whereas the 
94V360 and 08VA strains preferred  PK15S10–CD163. The 
highly virulent G1s3 strains (Su1-Bel and Lena) showed 
a strong preference for  PK15S1–CD163. Similarly, to the 
genotype 2 strain MN-184 in the previous infection assay, 
the other two genotype 2 strains, SDSU-73 and Korea17, 
also showed a higher infection rate in  PK15S10–CD163 as 
compared to  PK15S1–CD163 (84.3% vs 38.7% and 34.93% 
vs 18.7%, respectively). However, there were no signifi-
cant differences between  PK15S1–CD163 and  PK15S10–CD163 
upon infection with VR2332 and NADC30 strains. Some 
strains (08VA (G1s1), 13V117 (G1s1), VR2332 (G2)) were 
poor virus producers (<104  TCID50/mL), while other 
strains (07V063 (G1s1), 13V091 (G1s1), Su1-Bel (G1s3), 
MN-184 (G2), Korean17 (G2) and SDSU-73 (G2)) easily 
grew up to ≥106  TCID50/mL. To confirm that the virus 
particles are better attached to the  PK15S1–CD163 cells, 
leading to a lower efficiency in virus production, both 
intracellular and extracellular virus titrations were per-
formed for the ten genetically distant virus strains. Inter-
estingly, we found that  PK15S10–CD163 cells showed much 
higher extracellular than intracellular virus titers (average 
titer of 3.41  log10TCID50/mL vs 2.46  log10TCID50/mL, 
p = 0.005). However, for  PK15S1–CD163 cells, the intracel-
lular and extracellular virus titers were comparable (aver-
age titer of 2.31log10TCID50/mL vs 2.45  log10TCID50/mL, 
p = 0.564) (Additional file 2).
Discussion
In vivo, PRRSV shows a strict preference for certain mac-
rophage subsets, such as porcine alveolar macrophages 
(PAM). These primary porcine cells can be used for virus 
isolation and virus propagation, because they closely 
mimic the in vivo situation. However, using primary cell 
lines is expensive and may be a risk for contamination. 
More importantly, primary cells have a short lifespan and 
display a batch to batch variation. Apart from PAM, the 
other cell type known to be permissive to PRRSV is the 
immortalized monkey kidney cell line MA-104 and its 
derivatives, such as MARC-145 [11, 22]. This cell line is 
able to overcome the aforementioned problems and is 
routinely used for large scale production of PRRSV. How-
ever, the use of MARC-145 cell line is limited for virus 
isolation as some strains (most genotype 1 strains and 
a certain percentage of genotype 2 strains such as the 
Korean 17) do not grow in this cell line [23, 24]. In addi-
tion, the propagation of PRRSV in MARC-145 cells may 
lead to genetic changes [25]. The latter feature is used for 
the development of attenuated vaccines.
Non-permissive cells transiently transfected with 
CD163 may allow a low level of infection depending on 
the cell type used for virus replication [26]. Co-expres-
sion of Siglec-1 and the scavenger receptor CD163 are 
needed for an efficient PRRSV infection [27]. In our 
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search to find a cell line that combines the advantages 
of PAM and MARC-145, our laboratory has already 
successfully generated a PK15 cell line expressing both 
Siglec-1 and CD163  (PK15S1–CD163). However, we have 
recently shown that Siglec-1 is not the only entry media-
tor for PRRSV [18]. As for Siglec-1, Siglec-10 in com-
bination with CD163 is also able to improve PRRSV 
infection in non-permissive cells. Siglec-10 facilitates 
attachment and internalization of PRRSV. To assess if the 
receptor use differs between different PRRSV strains, we 
constructed a PK15 cell line recombinantly expressing 
Siglec-10 and CD163  (PK15S10–CD163). Expression of both 
receptors was confirmed with immunofluorescence and 
flow cytometry.
PRRSV entry in the target cells is initiated via virus-
receptor interaction. First, the virus binds to heparin 
sulphate as well as sialoadhesin, and then, virus is inter-
nalized via sialoadhesin through its interaction with 
the PRRSV GP5-M structural protein complex. Follow-
ing entry, CD163 coordinates disassembly and the fol-
lowing steps in the virus replication cycle. Previously, 
we have shown that  PK15S10 cells were able to bind and 
internalize PRRSV particles, however, no productive 
infection could be observed [18]. In this study, CD163 
was successfully introduced in the  PK15S10 cells. The 
complete replication cycle was analyzed and compared 
with those in  PK15S1–CD163 cells. As expected, both cell 
lines were susceptible for PRRSV infection. Attachment, 
Figure 5 Flow cytometric analysis of receptor subcellular expression pattern for PK15S1–CD163 and PK15S10–CD163 cell lines. Siglec-1, 
Siglec-10 and CD163 expression in the cytoplasm and on the plasma membrane of  PK15S1–CD163 (A) and  PK15S10–CD163 (B) cells were analyzed with 
flow cytometry. Surf = surface expression; cyto = surface + cytoplasmic expression; ISO = isotype-matched control
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internalization, disassembly and infection of LV occurred 
in both cell lines.
The binding and internalization were at a lower level 
in the  PK15S10–CD163 cells. We hypothesized that this 
was due to a different subcellular expression pattern of 
Siglec-1 and Siglec-10. Siglec-1 is expressed to higher lev-
els on the surface of the cells than Siglec-10. This might 
partly explain the more efficient binding and internali-
zation in  PK15S1–CD163 cells. As the CD163 expression 
is similar in both cell lines, the observed differences can 
only be attributed to the Siglec localization patterns.
In order to determine the efficiency of PRRSV infection 
and production in  PK15S10–CD163 compared to  PK15S1–
CD163 cells, a PRRSV replication kinetic experiment with 
14 different virus strains was performed. Information on 
these strains is listed in Table  1. Based on the phyloge-
netic tree analysis (Additional file 3), the 14 strains used 
for this study are genetically distant. Significant vari-
ability in growth characteristics among genetically dis-
tant strains was observed. Some strains [08VA (G1s1), 
13V117 (G1s1), VR2332 (G2)] were poor virus producers 
(<104  TCID50/mL), while other strains [07V063 (G1s1), 
13V091 (G1s1), Su1-Bel (G1s3), MN-184 (G2), Korean17 
(G2) and SDSU-73 (G2)] easily grew up to ≥106 TCID50/
mL. Interestingly, a previous study from Frydas et al. [16] 
has shown that the PRRSV strains LV, 08VA and 13V117 
were also categorized as poor growers, Lena and VR2332 
strains were moderate, while the 07V063, 13V091 and 
MN-184 strains were strong producers based on virus 
shedding in respiratory explants [15, 16]. The Korean17 
(G2) strain is a recent type 2 strain isolated from a farm 
with a severe outbreak of PRRS. Our results are consist-
ent with the idea that the virulence is associated with a 
faster replication in both cell lines. To further analyze the 
replication of all of the strains, we found that strains LV, 
07V063, Sul-Bel, Lena, VR2332 and NADC30 performed 
better in  PK15S1–CD163 cells, whereas 94V360, 08VA, 
13V091, 13V117, MN-184, SDSU-73 and Korean17 
strains preferred  PK15S10–CD163. Interestingly, the geno-
type 1 subtype 3 strains (Lena and Su1-Bel) showed a 
stronger preference for  PK15S1–CD163 cells, while the 
highly pathogenic type 2 strains (MN-184, SDSU-73, 
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Figure 6 Comparison of PRRSV infection kinetics in PK15S1–CD163 and PK15S10–CD163 for ten different strains. Immunofluorescence staining 
for PRRSV was performed in the two cell lines. After 0, 12, 24, 48 and 72 hpi, cells were fixed and stained for infection. The number of infected 
cells was counted and expressed as percentage of infected cells. The blue line represents infection rate/virus titers in  PK15S1–CD163 cells, while the 
red line represents infection rate/virus titers in  PK15S10–CD163 cells. G1s1 = genotype 1 subtype 1; G1s3 = genotype 1 subtype 3; G2 = genotype 2; 
S1 = PK15S1–CD163; S10 = PK15S10–CD163. Scale bar: 100 µm.
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Korean17) showed a higher affinity to  PK15S10–CD163 cells. 
The other two genotype 2 strains, VR2332 and NADC30, 
showed a slight preference to  PK15S1–CD163 cells. A pre-
vious study [15] revealed that VR2332 mainly infects 
 Sn+ cells in the lamina propria of the nasal mucosa, 
whereas the other genotype 2 strains (MN-184, VN) 
were also able to infect large number of  Sn- cells. This 
might explain the preference for the cell line observed in 
this study. No data for the NADC30 strain is available in 
the ex  vivo explant model. However, it was shown that 
NADC30 strain is relatively less pathogenic compared 
to MN-184 and SDSU-73 [28]. In return, we can assume 
that NADC30 might have a relatively more restricted cell 
tropism compared to the MN-184 and SDSU-73 strains. 
GP5 is the major glycoprotein of PRRSV. Sugar modifica-
tion of this viral glycoprotein is important for host–path-
ogen interactions and signaling recognition. Previously, 
we have shown that Siglec-1 interacts with the GP5/M 
heterodimer complex [12]. Siglec-10 functions in a sim-
ilar way as Siglec-1 in mediating the binding and inter-
nalizing of the virus in a sialic acid-dependent manner 
[18]. Here we further analyzed the amino acid sequence 
of GP5 for all of the virus strains used in our study with 
MEGA 6. The first two glycosylation sites (N at posi-
tion 10 and 17) are fully conserved and are present in all 
PRRSV strains, demonstrating its crucial role in the bind-
ing/internalization process. The third potential N-gly-
cosylation further away from the membrane is more 
variable (Figure 7). It is highly possible that this variation 
influences the attachment and internalization due to a 
siglec preference. The majority of type 2 strains (MN-184, 
SDSU-73 and Korean 17) carry around 3–4 glycosylation 
sites  (N10,  N17,  N27/N28/N29,  N31) and show a preference 
for Siglec-10. LV, VR2332 and Lena show a highly pref-
erence for Siglec-1. LV has only two glycosylation sites 
 (N10,  N17). Although VR2332 has four potential N-gly-
cosylation sites, only 2 or exceptionally 3N-glycosylation 
sites are used in nature  (N10,  N17, ± N28) [29, 30], with a 
poor glycosylation efficiency of the NDS sequon for  N28. 
What Lena concerns, a non-conserved mutation 42Q 
(polar uncharged) to 42L (hydrophobic) between  N17 
and  N26 glycosylation site was observed, which changes 
from an amino acid with an uncharged side chain into a 
hydrophobic side chain, which might have an impact on 
the glycosylation modification. However, whether the 
differences in N-glycosylation sites in the ectodomain 
of GP5 result in different glycosylation patterns that are 
related to the preference in usage of Siglecs needs further 
investigations.
The production of virus by infected cells is an essen-
tial process for the spread of viral diseases. Enveloped 
viruses can spread via two distinct routes, either through 
the cell-free aqueous environment or by direct cell–cell 
contact. In the present study, we found that the  PK15S10–
CD163 cell line exhibited a higher efficiency in virus release 
in the extracellular environment than the  PK15S1–CD163 
cell line (Additional file  1). The prototype strains (LV, 
Lena, VR2332) showed a much higher infection rate 
in the  PK15S1–CD163 cell line, but the virus titers in the 
supernatant were comparable in both cell lines. Two pos-
sible mechanisms may be forwarded for this phenome-
non. First, virus might use more cell-to-cell transmission 
in  PK15S1–CD163 cells as compared to  PK15S10–CD163 cells 
giving rise to a higher infection rate but lower virus 
release. Second, based on the surface and cytoplasm 
staining, Siglec-1 is more abundantly expressed on the 
surface of the cells providing more efficient binding and 
internalization, while Siglec-10 is mostly expressed in 
the cytoplasm. This might increase the chance that upon 
release from the cells, the virus particles bind back to 
the surface of the  PK15S1–CD163 cells. This hypothesis is 
supported by the observation that the extracellular titers 
were higher for the  PK15S10–CD163 cell line, while the 
intra- and extracellular virus titers are more or less the 
same for the  PK15S1–CD163 cell line (Additional file 1).
In summary, the observation that all tested virus strains 
replicate well in both  PK15S1–CD163 and  PK15S10–CD163 
cells suggesting that these cells might be useful for virus 
isolation. Today MARC-145 is the mostly used cell line 
for virus isolation, however, not all PRRSV strains grow 
on MARC-145 cells [11, 24]. PAM has a much higher effi-
ciency in virus isolation, but it is more variable and more 
difficult for routine maintenance. The two cell lines that 
we constructed could be an optimal replacement for both 
MARC-145 and PAM. In addition, the  PK15S10–CD163 cell 
line is more efficient in virus production, which is impor-
tant for the production of inactivated vaccines. Finally, 
the observed variability in growth characteristics of all 
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Figure 7 GP5 ectodomain amino acid and N-glycosylation site analysis for both type 1 and type 2 PRRSV strains. A graphic representation 
of an amino acid sequence alignment of the GP5 ectodomain, starting with the 1st amino acid (aa) at the plasma membrane. The potential 
glycosylation sites were indicated with colored boxes. The first N glycosylation site is  N10 which is 10 aa away from the membrane (indicated with 
grey boxes). The second N-glycosylation site  N17 is colored blue. The third or fourth N-glycosylation sites at  N26/N27 is colored green,  N28 is colored 
with purple and at  N31 is colored with red. Black arrows represent the signal peptide cleavage site for GP5 protein. The virus strains were ranked 
on the infection rate in Siglec-1 expressing cells. The ranking is represented with a heat map (Red represent a low percentage, yellow represents a 
medium percentage and green represent high percentage). The preferences for Siglec-1 and Siglec-10 were indicated with an infection ratio of S1/
S10 or S10/S1.
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the virus strains tested in both cell lines might be con-
nected with the outcome of a PRRSV infection and might 
be partially explained by the receptor usage.
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Additional file 1. Comparison of virus production per infected cell 
in PK-15S1–CD163 and PK15S10–CD163 cells. Blue bars represent the virus 
production per infected cells of PK-15S1–CD163. Red bars represent the virus 
production per infected cells of PK-15S10–CD163.
Additional file 2. Kinetics of intracellular and extracellular virus titers 
for 10 strains propagated in PK-15S1–CD163 and PK15S10–CD163 cells. 
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results for PK-15S10–CD163 cells.
Additional file 3. Phylogenetic tree of virus isolates used in the pre-
sent study. A molecular phylogenetic analysis of the full genome nucleo-
tide sequences was constructed using the Neighbor-Joining method. Phy-
logenetic relationships were estimated using the Clustal Omega method. 
The optimal tree is drawn to scale. Numbers indicate bootstrap values 
of 100 replicates. Strain nomenclature is as follows: GenBank accession 
number/Name of the isolate. Filled circles represent the strains used in the 
present study.
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